These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 8726518)

  • 1. Combination strategies for vaccination against HIV.
    Plotkin SA
    Antibiot Chemother (1971); 1996; 48():145-6. PubMed ID: 8726518
    [No Abstract]   [Full Text] [Related]  

  • 2. [AIDS vaccine].
    Sikorska EJ
    Pneumonol Alergol Pol; 1991; 59(3-4):146-52. PubMed ID: 1843911
    [No Abstract]   [Full Text] [Related]  

  • 3. [Pre-exposure infection self-treatment: the american follow-up].
    Nau JY
    Rev Med Suisse; 2012 May; 8(342):1140-1. PubMed ID: 22734186
    [No Abstract]   [Full Text] [Related]  

  • 4. Therapeutic vaccines for preventing AIDS: their use with HAART.
    Hoff R; McNamara J
    Lancet; 1999 May; 353(9166):1723-4. PubMed ID: 10347978
    [No Abstract]   [Full Text] [Related]  

  • 5. New hope for an AIDS vaccine.
    Robinson HL
    Nat Rev Immunol; 2002 Apr; 2(4):239-50. PubMed ID: 12001995
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chimpanzee pathogenic strains of HIV type 1.
    Prince AM
    AIDS Res Hum Retroviruses; 1997 Oct; 13(15):1259. PubMed ID: 9339841
    [No Abstract]   [Full Text] [Related]  

  • 7. [The virus can not yet be eradicated. "HIV-infected patients cannot be completely cured"].
    Hellbom K
    Krankenpfl J; 1998; 36(7-8):274. PubMed ID: 9775853
    [No Abstract]   [Full Text] [Related]  

  • 8. Immunization for long-term protection against AIDS using the macaque model.
    Kumar A; Narayan O
    Virology; 2001 Jun; 285(1):1-5. PubMed ID: 11414799
    [No Abstract]   [Full Text] [Related]  

  • 9. HIV-1/AIDS vaccine development: are we in the darkness.
    Qiu C; Xu JQ
    Chin Med J (Engl); 2008 May; 121(10):939-45. PubMed ID: 18706210
    [No Abstract]   [Full Text] [Related]  

  • 10. India targets local HIV strain in test of AIDS vaccine.
    Jayaraman KS
    Nature; 2004 Jan; 427(6971):185. PubMed ID: 14724601
    [No Abstract]   [Full Text] [Related]  

  • 11. [Vaccines against AIDS finally in sight? Vaccination campaigns in China and Uganda in preliminary stages].
    Wolf HJ
    Fortschr Med; 1995 Nov; 113(31):20, 22. PubMed ID: 8529980
    [No Abstract]   [Full Text] [Related]  

  • 12. HIV-1 step study.
    Dalgleish A; Stebbing J
    Lancet; 2009 Mar; 373(9666):805; author reply 806. PubMed ID: 19269507
    [No Abstract]   [Full Text] [Related]  

  • 13. Induction of HIV-specific memory T-cell responses by topical DermaVir vaccine.
    Calarota SA; Weiner DB; Lori F; Lisziewicz J
    Vaccine; 2007 Apr; 25(16):3070-4. PubMed ID: 17292518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mucosal-targeted AIDS vaccines: the next generation?
    Lekkerkerker AN; Van Kooyk Y; Geijtenbeek TB
    Trends Microbiol; 2004 Oct; 12(10):447-50. PubMed ID: 15381193
    [No Abstract]   [Full Text] [Related]  

  • 15. Candidate AIDS vaccines.
    Graham BS; Wright PF
    N Engl J Med; 1995 Nov; 333(20):1331-9. PubMed ID: 7566026
    [No Abstract]   [Full Text] [Related]  

  • 16. Introduction: Back to basics: mucosal immunity and novel HIV vaccine concepts.
    Broliden K; Haase AT; Ahuja SK; Shearer GM; Andersson J
    J Intern Med; 2009 Jan; 265(1):5-17. PubMed ID: 19093956
    [No Abstract]   [Full Text] [Related]  

  • 17. Steady but slow progress toward AIDS vaccine.
    Minn Med; 1993 Aug; 76(8):38-9. PubMed ID: 8371702
    [No Abstract]   [Full Text] [Related]  

  • 18. Just (don't) do it.
    Schooley RT
    J Clin Invest; 1993 Aug; 92(2):535. PubMed ID: 8349794
    [No Abstract]   [Full Text] [Related]  

  • 19. Prime-boost strategies in DNA vaccines.
    Dale CJ; Thomson S; De Rose R; Ranasinghe C; Medveczky CJ; Pamungkas J; Boyle DB; Ramshaw IA; Kent SJ
    Methods Mol Med; 2006; 127():171-97. PubMed ID: 16988455
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunological aspects of patients with HIV-1 disease following immunization with recombinant gp160 (VaxSyn).
    Guerra E; Ricci G; Carlesimo M; Varani AR; Pontesilli O; Scala E; Mezzaroma I; Pierdominici ; Pandolfi F; Antinori A; De Luca A; Murri R; Ammassari A; Ortona L; Aiuti F
    Antibiot Chemother (1971); 1996; 48():147-54. PubMed ID: 8726519
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.